What Should a Regenerative Medicine Clinic Review in Its Monthly Ad Performance Meeting? (A Real July 1st Review, Line by Line)
On July 1st we sat down with a cash-pay regenerative medicine clinic — joint pain and PRP, body contouring, hormones — and ran the monthly review we run with every client: last month’s numbers against the month before AND the same month in prior years.
June: 33 new patients, 126 uniques, 58 website leads, 370 inbound calls, revenue up $20K year-over-year in a normally slow month.
And one campaign resurrection worth the whole meeting: the pain ads had produced 1–2 leads a month all spring — until a mid-month landing-page swap turned them into 3–4 leads in the final six days.
Same keywords. Same spend.
Here’s the FAQ on running this review at your own clinic.
What metrics should my clinic review at the end of each month?
Six pulls, every month, on the 1st: new patients, unique patients, website leads, ad leads by source, bookings by source, and inbound calls (total and first-time).
This clinic’s June board: 33 new patients (May: 35), 126 unique patients (116), 58 website leads (65), 46 body-contouring leads from Google with 7 booked, 50 total Google leads with 9 booked, and inbound calls up from 302 to 370 — first-time calls from 132 to 169.
Two comparisons matter, not one.
Last month tells you momentum. The same month last year tells you whether “down” is a problem or just July.
This clinic’s new-patient history read 13, 12, 27, 34, 35, 22, 35, 33 across eight months.
Without the seasonal context, April’s 22 looks like a crisis instead of an outlier.
Why are my Google Ads getting clicks but no leads?
Check the landing page before you touch the ads.
This clinic kept keywords and spend identical, swapped in a symptom quiz, and the dead campaign revived in six days.
The pain campaign had spent months producing 1–2 leads a month.
The diagnosis wasn’t targeting or budget: “chat and AI has trained people to want answers faster,” and a static landing page asks a person in pain to read, scroll, and hope.
The replacement quiz asks what a consult would ask — which joint, how long, severity 1–10, whether surgery was recommended, what they’ve tried, what it stops them from doing, timeline, locality — and ends with an opt-in.
The result: “same keywords, same spend, changed nothing other than the page,” and leads went from 1–2 a month to 3–4 in the last six days of June.
One of them was a mother booking a consult for her son, a baseball pitcher trying to avoid surgery.
The quiz converts because it qualifies and validates simultaneously.
The lead finishes thinking, “I do qualify for a consultation.”
That mechanism is central to regenerative medicine marketing, where the patient is high-consideration, often surgery-averse, and researching hard before they call anyone.
Should I pause seasonal campaigns in the summer?
If the treatment has downtime and your market’s good-weather window is short — yes.
Reallocate; don’t just spend onward.
The July decision from this review was to hold the body-contouring spend until September.
Summer downtime plus a short good-weather season made conversion unlikely.
Instead, the clinic pushed the pain campaign — freshly revived, similar case value, and not season-dependent.
That’s the actual point of a monthly review: not admiring the dashboard, but moving money.
A campaign that made sense in March can be the wrong campaign in July with nothing “broken” at all.
How long should I test a new campaign before scaling?
About seven days of monitoring with a concrete booking goal — then scale what hits, fix what doesn’t.
The reallocated pain campaign got a specific target: three to four booked consults per campaign, checked after the first week.
The number matters more than the interval.
“Watch it for a while” is how campaigns run unjudged for a quarter.
Seven days, a booking goal, and a decision: scale, fix, or kill.
This cadence also protects against the opposite failure — killing a campaign on day three before the algorithm has settled.
Is 30 new patients a month good for a cash-pay clinic?
Context decides.
Against this clinic’s own history, 33 was a strong June: the winter floor was 12–13, the spring run 27–35, and June revenue came in $20K up year-over-year in a slow month.
Benchmarks from other clinics are mostly noise.
Benchmarks from your own trailing 24 months are signal.
That’s also why the review compares to the same month in prior years.
And when the numbers hold up under seasonal context, the compounding is real: a pain-management practice we work with added $2,095,039 in revenue in just 10 months running exactly this loop — monthly numbers, diagnosis, reallocation, repeat.
Can I run paid ads to a $99 consult offer?
It’s risky.
This clinic’s consults were $99 with labs near cost, and the honest assessment was: “if we ever wanted to run paid ads to this… it would be hard to make the money make sense if you didn’t charge more.”
Ad math needs margin to feed on.
The benchmark shown on this call was a membership clinic charging $550 for initial labs with a mobile phlebotomist, a $350 consult credited to month one, and $375/month programs — 275 members, built without paid ads.
The principle: attach the price to what the patient believes they need, so the monthly charge justifies itself.
Underpriced offers don’t just cap revenue.
They mathematically lock you out of paid acquisition because every acquired patient loses money until the pricing is fixed.
Fix the offer first, then buy traffic.
FAQ’s About Monthly Ad Reviews for Regenerative Clinics
Who should be in the monthly ad review meeting?
The owner, whoever runs marketing — in-house or agency — and the front desk lead.
The front desk lead is the person who hears why patients do and don’t book.
This clinic’s front desk had built her own SMS follow-up workflows. The review is where that ground truth meets the spend data.
What does a symptom quiz for joint-pain ads actually ask?
This clinic’s version: which joint, how long it’s hurt, severity 1–10, whether surgery was recommended, what they’ve tried, what the pain stops them from doing, treatment timeline, locality, and contact opt-in.
They’re the same qualifying questions a consult would open with.
Why compare against the same month last year instead of just last month?
Seasonality.
This clinic’s June was “up $20K versus last June, and about $25K versus two years ago” — in a month that’s reliably slow.
Month-over-month alone would have read the same June as flat.
When a lead from one campaign buys a different service, how do I count it?
Count it — and note the crossover.
Several of this clinic’s body-contouring leads converted into hormone patients instead.
The campaign gets credit for the patient, and the crossover pattern feeds next month’s offer decisions.
What’s the minimum a clinic needs before this review works?
Source-tagged leads and bookings.
If you can’t split leads and bookings by source, the meeting has no verbs.
Start there, then the review runs in under an hour a month.
What’s the next step?
If your ad spend gets judged by feel — or not judged at all — you’re one landing-page swap away from either a revival or a quiet money leak, and you don’t know which.
Book a strategy call.
In 60 minutes we’ll run this exact review on your last two months: numbers by source, seasonal context, and the reallocation the data actually supports.